Baron and Budd Applauds the Development of a New Drug for the Treatment of Mesothelioma

Known as VS-6063, or defactinib, this cancer-stem-cell inhibitor manufactured by Verastem Inc. was given orphan drug designation by the FDA for treatment of mesothelioma.

Source: www.topix.com Via newsmixx: home News